Garrison Bradford & Associates’s VolitionRx Ltd VNRX Stock Holding History
Bought
Maintained
Sold
Other funds holding VNRX
LIM
BCM
CPA
Garrison Bradford & Associates's VNRX Position: Q2 2022 in Review
Garrison Bradford & Associates sold out of VolitionRx Ltd (VNRX) in Q2 2022, closing a stake of 775 shares — an estimated $47K sold.
Garrison Bradford & Associates first reported a position in VNRX in Q1 2015 and held it in 29 quarters. The position peaked at $87K in Q3 2019. 31 funds tracked by Wall St. Rank hold VNRX as of Q2 2022.
- Garrison Bradford & Associates reported no remaining VolitionRx Ltd position as of Q2 2022 after selling out during the quarter.
- Garrison Bradford & Associates sold 775 VolitionRx Ltd shares in Q2 2022, an estimated $47K.
- Garrison Bradford & Associates first reported a position in VolitionRx Ltd in Q1 2015 and held it in 29 quarters.
- Garrison Bradford & Associates's VolitionRx Ltd position peaked at $87K in Q3 2019.
- 31 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q2 2022.
Based on Garrison Bradford & Associates's 13F filing for Q2 2022, filed 23 Aug 2022.